These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16578966)

  • 21. New Approach for Inhibition of HIV Entry: Modifying CD4 Binding Sites by Thiolated Pyrimidine Derivatives.
    Kanizsai S; Ongrádi J; Aradi J; Nagy K
    Pathol Oncol Res; 2016 Jul; 22(3):617-23. PubMed ID: 26860867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
    Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
    Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus.
    Robinovitch MR; Iversen JM; Resnick L
    Crit Rev Oral Biol Med; 1993; 4(3-4):455-9. PubMed ID: 8397002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
    Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
    J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
    Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
    Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction.
    Guillon C; Schutten M; Boers PH; Gruters RA; Osterhaus AD
    J Virol; 2002 Mar; 76(6):2827-34. PubMed ID: 11861850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-HIV-1 activity associated with saliva.
    Shine N; Konopka K; Düzgüneş N
    J Dent Res; 1997 Feb; 76(2):634-40. PubMed ID: 9062556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein.
    Shine NR; Wang SC; Konopka K; Burks EA; Düzgüneş N; Whitman CP
    Bioorg Chem; 2002 Aug; 30(4):249-63. PubMed ID: 12392704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
    Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type-1 Tat protein induces secretory leukocyte protease inhibitor expression in African green monkey but not human cells.
    Özdemir S; Şengez B; Arslanoğlu A
    Virus Genes; 2020 Apr; 56(2):182-193. PubMed ID: 31925640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M; Baranyi L; Okada N; Okada H
    Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
    Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
    AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes.
    Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A
    Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.
    Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L
    Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Position 22 of the V3 loop is associated with HIV infectivity.
    Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
    Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tropism-restricted neutralization by secretory IgA from parotid saliva of HIV type 1-infected individuals.
    Wu X; Hall S; Jackson S
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):275-81. PubMed ID: 12804003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
    Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.